Drug profile · INN
tetracaine hydrochloride
TETRACAINE HYDROCHLORIDE
tetracaine hydrochloride (TETRACAINE HYDROCHLORIDE) is a sodium channel alpha subunit blocker. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — tetracaine hydrochloride
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
tetracaine hydrochloride (TETRACAINE HYDROCHLORIDE) is a sodium channel alpha subunit blocker. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Sodium channel alpha subunit blocker
Primary target: Sodium channel alpha subunit
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is tetracaine hydrochloride?
tetracaine hydrochloride (TETRACAINE HYDROCHLORIDE) is a sodium channel alpha subunit blocker. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for tetracaine hydrochloride?
TETRACAINE HYDROCHLORIDE is a marketed brand name for tetracaine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tetracaine hydrochloride?
tetracaine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.